Trial Profile
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 10 Mg Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atrasentan (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Sponsors Abbott Laboratories
- 09 Nov 2005 New trial record.